Structure |
Chemical Name |
CAS |
MF |
|
Cephalexin Sulfoxide |
56193-21-6 |
C16H17N3O5S |
|
N-Butyl Nor ScopolaMine Hydrochloride |
22235-98-9 |
C20H28ClNO4 |
|
(17R)-3-オキソ-11β,17-ジヒドロキシ-19-ノルプレグナ-4,9-ジエン-21-ニトリル |
86153-39-1 |
C20H25NO3 |
|
2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity |
116182-44-6 |
C26H43NaO9 |
|
3-Hydroxy CitalopraM |
411221-53-9 |
C20H21FN2O2 |
|
5-(オキシラニルメトキシ)-2,3,4,9-テトラヒドロカルバゾール |
58457-32-2 |
C15H17NO2 |
|
Tafluprost Impurity 17 |
|
|
|
6α-Methyl Hydrocortisone 21-HeMisuccinate |
119657-85-1 |
C26H36O8 |
|
7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプト-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-1,4-ジヒドロ-4-オキソ-3-キノリンカルボン酸 |
127199-06-8 |
C19H18ClF2N3O3 |
|
rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine |
58827-68-2 |
C9H13N3O3S |
|
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
|
Hydroxy Varenicline N-Trifluoroacetate |
357426-10-9 |
C15H12F3N3O2 |
|
rac a-Hydroxy Ibuprofen |
60057-62-7 |
C13H18O3 |
|
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |
|
3a,7a-dihydroxy-5-(1-methyl-1H-indole-3-carbonyl)-hexahydro-1H-benzo[d]imidazol-2(3H)-one |
171967-74-1 |
C17H19N3O4 |
|
5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one |
139756-31-3 |
C16H17ClN4O4S |
|
5,7-ジフルオロクロマン-4-オン |
844648-22-2 |
C9H6F2O2 |
|
2-フルオロビフェニル-4-カルボン酸 |
137045-30-8 |
C13H9FO2 |
|
テオフィルリジン塩酸塩 |
116131-08-9 |
C6H10ClN4O |
|
1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole |
887583-89-3 |
C19H20N4 |
|
Tetracyclics compound impurities |
|
|
|
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
|
N'-(1-Methylazepan-4-yl)benzohydrazine |
117078-69-0 |
C14H22ClN3O |
|
3-アセチルオキシ-2-ブテン酸エチル |
29214-62-8 |
C8H12O4 |
|
2-(ブロモメチル)-2-(2,4-ジクロロフェニル)-1,3-ジオキソラン-4-メタノール |
68751-57-5 |
C11H11BrCl2O3 |
|
INDEX NAME NOT YET ASSIGNED |
2511244-96-3 |
C27H36N2O6 |
|
Oseltamivir Impurity 91 |
|
|
|
Oseltamivir Impurity 80 |
|
|
|
Oseltamivir Impurity 72 |
|
|
|
4(1H)-Quinazolinone, 6,8-dibromo-3-cyclohexyl-2,3-dihydro- |
2512203-87-9 |
C14H16Br2N2O |
|
Linagliptin impurity KH-3 |
2279114-27-9 |
C30H37N7O6 |
|
11β-ヒドロキシ-21-アセトキシプレグナ-1,4,16-トリエン-3,20-ジオン |
3044-42-6 |
C23H28O5 |
|
1-[(1,1-ジメチルエチル)アミノ]-3-[[4-(4-モルホリニル)-1,2,5-チアジアゾール-3-イル]オキシ]-2-プロパノール・マレイン酸 |
57073-55-9 |
C17H28N4O7S |
|
Ampicillin Impurity U |
|
|
|
Canagliflozin Hydroperoxide Impurity |
|
|
|
(E)-2-hydroxy-4-(phenyldiazenyl)benzoic acid |
40038-46-8 |
C13H10N2O3 |
|
Sitagliptin EP Impurity 6 |
|
|
|
Vonoprazan-005 |
2514735-09-0 |
C33H27F3N4 |
|
D-erythro-Hexonic acid, 6-S-2-benzothiazolyl-2,4-dideoxy-6-thio-, 1,1-dimethylethyl ester |
1469771-46-7 |
C17H23NO4S2 |
|
Palbociclib Impurity 37 |
|
|
|
Pazufloxacin Impurity 16 |
165071-10-3 |
C14H10FNO6 |
|
Pimecrolimus Impurity 4 |
|
|
|
Posaconazole Impurity 73 |
|
|
|
Rosuvastatin Impurity 90 |
2226413-62-1 |
C38H44F2N6O8S2 |
|
Tofacitinib Impurity 110 |
|
|
|
Tofacitinib Impurity 115 |
|
|
|
Trelagliptin Impurity 27 |
|
|
|
Vildagliptin Impurity 30 |
918830-94-1 |
C10H17NO2 |
|
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-2-amine |
|
C13H19N5 |
|
Tolvaptan Impurity 6 |
1432725-24-0 |
C18H19ClN2O2 |
|
Esmolol impurity B |
|
|
|
Esmolol impurity F |
|
|
|
Diquafosol Impurity E |
|
|
|
Bortezomib Impurity 39 |
|
|
|
3-(3-Chloropropyl)-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
85175-65-1 |
C15H20ClNO3 |
|
N-DesMethyl TelMisartan |
144701-81-5 |
C32H28N4O2 |
|
N-De[2-(Methylsulfonyl)ethyl] Lapatinib |
697299-82-4 |
C26H20ClFN4O2 |
|
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide |
957470-58-5 |
C24H24F2N4O5S |
|
3-Oxo Rosuvastatin SodiuM Salt |
1346606-28-7 |
C22H25FN3NaO6S |
|
Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride) |
246021-75-0 |
C10H16ClN5O2 |
|
Olopatadine USP RC B |
173174-07-7 |
C21H23NO4 |
|
Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) |
108313-11-7 |
C22H30N2O5 |
|
4'-(Difluoromethoxy)acetanilide |
22236-11-9 |
C9H9F2NO2 |
|
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-28-2 |
C24H30ClN7O4S |
|
N-carbaMoyl-2-Methyl benzene sulfonaMide |
39051-77-9 |
C8H10N2O3S |
|
Capecitabin iMpurity |
71609-08-0 |
C9H12FN3O4 |
|
4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride) |
|
|
|
Ibuprofen IMp. I (EP): 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-Methylpropyl)phenyl]butyl]benzene |
|
|
|
3-Quinolinecarboxylic acid, 7-[(7S)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-, hydrate |
163253-37-0 |
C19H20ClF2N3O4 |
|
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid |
61260-15-9 |
C10H11O5P |
|
1-(4,8-bis-(2,2,2-trifluoroacetyl)-11-{4-[4,8,11-tris-(2,2,2-trifluoroacetyl)-1,4,8,11-tetraazacyclotetradec-1-ylMethyl]-benzyl}-1,4,8,11-tetraazacyclotetradec-1-yl)-2,2,2-trifluoroethanone |
406939-93-3 |
C40H48F18N8O6 |
|
EMtricitabine iMpurity C |
|
|
|
(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide |
|
|
|
1-Demethyl Hydroxy Daunomycinone |
58199-98-7 |
C20H16O9 |
|
(S)-2-(butylsulfonamido)-3-(4-(4-(1-methylpiperidin-4-yl)butoxy)phenyl)propanoic acid |
1631053-75-2 |
C23H38N2O5S |
|
Loxoprofen Sodium Impurity 35 |
|
|
|
Dashatinib impurity 46 |
|
|
|
(R,S)Nアセチル3,4ジメトキシフェニルアラニン |
27313-65-1 |
C13H17NO5 |
|
Oxytocin oxide impurity reference substance |
|
|
|
Troxipide Impurity 7 |
|
|
|
Bendamustine Impurity 37A |
|
|
|
Brivaracetam Impurity 50 |
|
|
|
6-Hydroxymoxifloxacin Impurities |
|
|
|
(S)-4-(((R)-1-carboxy-2-((3-hydroxypropyl)thio)ethyl)amino)-3-hydroxy-4-oxobutanoic acid |
|
|
|
(S)-dimethyl 2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioate |
67676-60-2 |
C22H27ClN8O5 |
|
NA |
|
|
|
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
|
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
|
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
|
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
|
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
|
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
|
Vonoprazan Impurity B-2 |
|
|
|
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
|
Budesonide Impurity 31 |
|
|
|
Budesonide Impurity 23 |
|
|
|
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
|
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
|
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
|
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |